Status of surgical treatment procedures for endometrial cancer in Japan: results of a Japanese Gynecologic Oncology Group survey
- PMID: 17267025
- DOI: 10.1016/j.ygyno.2006.12.015
Status of surgical treatment procedures for endometrial cancer in Japan: results of a Japanese Gynecologic Oncology Group survey
Abstract
Objective: We investigated the current status of surgical procedures for endometrial carcinoma in Japan by surveying members of the Japan Gynecologic Oncology Group (JGOG).
Methods: A mail survey focusing on hysterectomy procedures, indications for radical hysterectomy, methods for detecting pelvic (PEN) and para-aortic lymph node (PAN) status, and indications for PAN dissection/biopsy, was sent to all 215 authorized JGOG member institutions.
Results: A total of 139 (57.2%) members responded to the survey. Abdominal total hysterectomy (TAH) was utilized by 35.3% of institutions and Piver class II extended hysterectomy by 30.2%. In 35.5% of institutions, hysterectomy procedures were selectively employed based on tumor-related factors. Radical hysterectomy (RH) was utilized by 29.5% of institutions; TAH was used significantly more frequently by specialist hospitals while RH was significantly less commonly utilized by specialist hospitals compared with university hospitals and general hospitals. PEN dissection was routinely utilized by 97.8% of institutions. In 93.5% of institutions, PAN dissection/biopsy was used either routinely (12.2%) or selectively based on tumor-related factors (81.2%). In 6.5% of institutions, PAN dissection/biopsy has never been employed.
Conclusion: The status of surgical procedures for the treatment of endometrial cancer is still not standardized. However, TAH, bilateral salpingo-oophorectomy, PEN dissection, and PAN dissection/biopsy in selected cases are recent surgical procedures used for the treatment of endometrial cancer in Japan. Clinical trials to determine the survival benefit of the different surgical procedures should be developed to determine the standard surgical procedures to be used for the treatment of endometrial cancer.
Similar articles
-
Practice pattern for postoperative management of endometrial cancer in Japan: a survey of the Japanese Gynecologic Oncology Group.Gynecol Oncol. 2009 Dec;115(3):456-9. doi: 10.1016/j.ygyno.2009.08.016. Epub 2009 Sep 17. Gynecol Oncol. 2009. PMID: 19765806
-
Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.Gynecol Oncol. 2007 Nov;107(2):253-9. doi: 10.1016/j.ygyno.2007.06.009. Epub 2007 Jul 19. Gynecol Oncol. 2007. PMID: 17640720
-
The value of laparoscopic surgery to stage gynecological cancers: present and future.Minerva Ginecol. 2009 Aug;61(4):319-37. Minerva Ginecol. 2009. PMID: 19745797 Review.
-
Can we omit para-aorta lymph node dissection in endometrial cancer?Jpn J Clin Oncol. 2006 Sep;36(9):578-81. doi: 10.1093/jjco/hyl066. Epub 2006 Jul 26. Jpn J Clin Oncol. 2006. PMID: 16870694
-
[Surgical treatment of endometrial cancer].Gan No Rinsho. 1990 Aug;36(10):1149-54. Gan No Rinsho. 1990. PMID: 2214153 Review. Japanese.
Cited by
-
Survival advantage of lymphadenectomy in endometrial cancer.J Cancer Res Clin Oncol. 2016 May;142(5):1051-60. doi: 10.1007/s00432-015-2109-9. Epub 2016 Jan 8. J Cancer Res Clin Oncol. 2016. PMID: 26746654 Free PMC article.
-
An antibody-drug conjugate for endometrioid carcinoma based on the expression of cell adhesion molecule 1.Mol Cell Oncol. 2024 Sep 5;11(1):2399379. doi: 10.1080/23723556.2024.2399379. eCollection 2024. Mol Cell Oncol. 2024. PMID: 39252827 Free PMC article.
-
Risk factors for paraaortic lymph node metastasis in endometrial cancer.Int J Clin Oncol. 2017 Oct;22(5):937-944. doi: 10.1007/s10147-017-1139-5. Epub 2017 May 18. Int J Clin Oncol. 2017. PMID: 28523533
-
Prognostic significance of adjuvant chemotherapy in stage I-II endometrial carcinoma patients who underwent lymphadenectomy.Int J Clin Oncol. 2024 Sep;29(9):1380-1390. doi: 10.1007/s10147-024-02560-w. Epub 2024 Jun 19. Int J Clin Oncol. 2024. PMID: 38896181
-
Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition.Int J Clin Oncol. 2010 Dec;15(6):531-42. doi: 10.1007/s10147-010-0138-6. Epub 2010 Nov 11. Int J Clin Oncol. 2010. PMID: 21069552
MeSH terms
LinkOut - more resources
Full Text Sources